{"id":"NCT01597505","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","briefTitle":"Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)","officialTitle":"A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-16","primaryCompletion":"2015-03-20","completion":"2015-03-20","firstPosted":"2012-05-14","resultsPosted":"2018-02-28","lastUpdate":"2019-07-23"},"enrollment":606,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Difficile Infection"],"interventions":[{"type":"DRUG","name":"Surotomycin","otherNames":["CB-183,315"]},{"type":"DRUG","name":"Vancomycin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Surotomycin","type":"EXPERIMENTAL"},{"label":"Vancomycin","type":"ACTIVE_COMPARATOR"}],"summary":"606 participants with Clostridium Difficile Associated Diarrhea (CDAD) participated in this study and received either oral vancomycin or CB-183,315 (surotomycin) in a blinded fashion. Treatment lasted for 10 days and participants were followed up for at least 40 days and a maximum of 100 days. The purpose of this study was to evaluate how well surotomycin treats CDAD as compared to vancomycin.","primaryOutcome":{"measure":"Adjusted Percentage of Participants With a Clinical Outcome of Cure at the End of Treatment (EOT)","timeFrame":"Up to 13 days","effectByArm":[{"arm":"Surotomycin","deltaMin":79,"sd":null},{"arm":"Vancomycin","deltaMin":83.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28480267","32747931"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":44,"n":305},"commonTop":["Nausea","Headache","Abdominal pain"]}}